HDAC9 and diabetic kidney disease: Beyond tolerability, given the breadth of action of HDACs, isoform-selectivity is likely to be an important determinant of the success of HDAC inhibition if it is to be adopted into clinical practice for the treatment of diabetic kidney disease.